Startseite Replicating viral vector platform exploits alarmin signals for potent CD8(+) T cell-mediated tumour immunotherapy.
|

Replicating viral vector platform exploits alarmin signals for potent CD8(+) T cell-mediated tumour immunotherapy.

Seite drucken
Seite teilen
DRFZ NewsFlash abonnieren